CON vs VRTX · P/E 18, rev $1.90B vs P/E 30, rev $12.00B
Concentra Group Holdings Parent, Inc. (CON) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Concentra Group Holdings Parent, Inc. (CON) is a medical care facilities company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported CON revenue for 2024-12-31 was $1.90B. Net income was $171.9M. Revenue was up 3.4% from 2023-12-31 to 2024-12-31. CON currently screens at market cap $3.18B and trailing P/E 17.9.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
CON currently screens at market cap $3.18B and trailing P/E 17.9. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the CON and VRTX stock pages for the full models.
Not investment advice.